D-dimer – Medxy AI

Application of the AHA-Proposed Cancer-Related Ischemic Stroke Classification: Reclassification and Prognostic Impact

By MedXY 06/03/2026

The AHA-proposed CRIS classification reclassified many cancer-associated strokes previously labeled cryptogenic and identified a subgroup with markedly worse survival, improving both etiologic clarity and prognostic stratification.

Emergency Medicine news Respiratory

Simplifying Pulmonary Embolism Exclusion: Can One Clinical Question Safely Reduce Imaging?

By MedXY 01/14/2026

A prospective multicenter study demonstrates that using a single clinical question—whether pulmonary embolism is the most likely diagnosis—to adjust D-dimer thresholds can safely reduce chest imaging by 19% in emergency departments without compromising patient safety.

Emergency Medicine Internal Medicine news

Age-Adjusted D-Dimer Cutoffs Safely Rule Out Deep Vein Thrombosis: Results from the ADJUST-DVT Trial

By MedXY 01/06/2026

The ADJUST-DVT study confirms that an age-adjusted D-dimer cutoff (age × 10 µg/L) safely increases the number of patients in whom deep vein thrombosis can be ruled out without imaging, particularly benefiting patients over 75 years of age.

Cardiology Critical Care news

Elevated Admission D-dimer: A Potent New Predictor of In-Hospital Mortality in Takotsubo Syndrome

By MedXY 01/05/2026

A retrospective study of 580 TTS patients demonstrates that admission D-dimer levels ≥3.5 µg/mL are associated with a seven-fold increase in in-hospital mortality, significantly improving the predictive accuracy of the traditional InterTAK Prognostic Score.

Hematology-Oncology Specialties

Venous Thromboembolism in Newly Diagnosed Lymphoma Patients: Insights from a Real-World Vietnamese Cohort

By MedXY 08/26/2025

An 8.3% incidence of VTE was observed in newly diagnosed lymphoma patients in Vietnam, with pretreatment elevated D-dimer and cardiovascular comorbidities as key risk factors, emphasizing the need for tailored thromboprophylaxis.